Natco Pharma informs about press release

02 Jan 2017 Evaluate

Natco Pharma has informed about a Press Release dated January 02, 2017 titled ‘NATCO launches VELPANAT in Nepal- 1st generic version of Sofosbuvir 400mg/Velpatasvir 100mg fixed dose combination medicine in the country’.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

887.70 -15.85 (-1.75%)
01-Jan-2026 13:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.10
Dr. Reddys Lab 1250.00
Cipla 1499.50
Zydus Lifesciences 912.80
Lupin 2100.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×